Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Nicolle

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Neurology|November 4, 2020
International Consensus Guidance for Management of Myasthenia Gravis: 2020 UpdatePushpa Narayanaswami, Donald B Sanders, Gil Wolfe, et al.
Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.
European Neurology|October 28, 2019
A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis ExacerbationsGuntis Karelis, Rodica Balasa, Jan L De Bleecker, et al.
Brain : a Journal of Neurology|June 23, 2026
Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwideAngela Vincent, Rehab Badi, Nina Barisic, et al.
JAMA Neurology|February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Neurology|November 4, 2020
International Consensus Guidance for Management of Myasthenia Gravis: 2020 UpdatePushpa Narayanaswami, Donald B Sanders, Gil Wolfe, et al.
Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.
European Neurology|October 28, 2019
A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis ExacerbationsGuntis Karelis, Rodica Balasa, Jan L De Bleecker, et al.
Brain : a Journal of Neurology|June 23, 2026
Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwideAngela Vincent, Rehab Badi, Nina Barisic, et al.
JAMA Neurology|February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.
Pageof 2